New perspective proposes that skin microbiota disruption and bathing habits may play a primary role in atopic dermatitis, ...

A focused update to AAD’s adult AD guidelines recommends tapinarof, roflumilast, lebrikizumab, and nemolizumab based on ...

Atopic dermatitis affects approximately 200 million people worldwide, including about 26 million individuals in the United States. Despite its prevalence, ...